Hair Loss After Ozempic, Wegovy, or Zepbound: What's Happening, and What Can You Do?

Noticing more hair in your shower or brush after starting a weight-loss medication? Hair shedding can occur during significant weight loss, but understanding why it's happening is the first step toward deciding what to do about it.

Medications such as Ozempic, Wegovy, and Zepbound have changed the treatment of obesity and related medical conditions. Ozempic and Wegovy contain semaglutide, a GLP-1 receptor agonist. Zepbound contains tirzepatide, which acts on both GIP and GLP-1 receptors.

But some patients taking these medications notice an unexpected change: increased hair shedding.

Hair loss has been reported in clinical trials of weight-loss medications, with rates of approximately 3–7% in some studies. The frequency varies by medication, population, and study, and not all reports establish that the medication itself caused the hair loss.

For some people, shedding is temporary. For others, weight loss may reveal an underlying pattern of hair thinning that was already developing.

The important question isn't simply whether your medication is causing hair loss. It's what kind of hair loss you're experiencing—and whether treatment would help.

Why do Ozempic, Wegovy, and Zepbound cause hair loss?

One common explanation for hair shedding during significant weight loss is a condition called telogen effluvium.

Hair normally moves through cycles of growth, transition, and shedding. Significant physical stress, including rapid weight loss, can cause more follicles than usual to enter the resting phase.

Several months later, those hairs begin shedding, sometimes quite dramatically.

This isn't unique to GLP-1 medications. Similar shedding can occur after major illness, surgery, childbirth, or substantial weight loss from other causes.

Nutritional changes may also contribute. Reduced calorie intake, inadequate protein, or deficiencies in nutrients such as iron can affect hair growth.

Research suggests that the amount and speed of weight loss may influence the risk of shedding. Some observational studies have reported higher rates of hair loss among women and people experiencing greater weight reduction, but there is no established percentage of weight loss at which hair shedding becomes inevitable.

Hair loss has also been reported with both semaglutide and tirzepatide, although the strength of the association varies across studies.

Whether these medications directly affect hair follicles, independently of weight loss and nutritional changes, remains uncertain.

When does hair loss start after taking a GLP-1 medication?

Telogen effluvium often becomes noticeable about two to four months after a triggering event.

You might see more hair coming out when washing or brushing, or notice that your ponytail feels thinner.

Unlike classic pattern hair loss, telogen effluvium usually causes more diffuse shedding rather than thinning concentrated along the part, crown, or temples.

The timing can vary, especially when weight loss occurs over several months rather than after one distinct event.

This delay can also make it difficult to recognize the connection between shedding and an earlier period of rapid weight loss.

Does hair grow back after Ozempic, Wegovy, or Zepbound?

Often, yes—particularly when the cause is uncomplicated telogen effluvium.

Once the underlying trigger has resolved, excessive shedding typically improves over the following months. Many cases of acute telogen effluvium settle within approximately six months, although recovery of visible hair density often takes six to twelve months or longer.

If weight loss is continuing rapidly, nutritional intake remains inadequate, or another contributing condition is present, shedding may persist.

Shedding that persists for more than six months may be classified as chronic telogen effluvium, but persistent shedding also warrants evaluation for ongoing triggers or other causes of hair loss.

With GLP-1 medications, the timeline can be less predictable because weight loss may continue for many months rather than occurring after a single triggering event.

And if weight loss has revealed an underlying pattern of hair thinning, that component may not resolve on its own.

This is why identifying the type of hair loss matters more than assuming all shedding during GLP-1 treatment will follow the same course.

Can protein intake or nutritional deficiencies contribute to hair loss?

Yes. Hair growth depends on adequate nutrition. During significant weight loss, reduced food intake can make it more difficult to meet protein and other nutritional needs.

Inadequate protein intake, iron deficiency, and certain other nutritional deficiencies may contribute to hair shedding.

However, taking additional vitamins or supplements isn't necessarily helpful if you don't have a deficiency.

If you're experiencing substantial hair loss while losing weight, your clinician may review your dietary intake, rate of weight loss, symptoms, and medical history.

Depending on the circumstances, laboratory testing may include:

  • Ferritin and iron studies to evaluate iron stores or possible iron deficiency
  • Thyroid-stimulating hormone (TSH) to assess for thyroid dysfunction
  • Vitamin D testing when deficiency is suspected or relevant risk factors are present
  • Other testing guided by symptoms, medical history, and examination findings

Not everyone needs the same tests.

The goal is to identify and address a contributing problem rather than assume that every patient needs a supplement or an extensive laboratory workup.

Should you stop Ozempic, Wegovy, or Zepbound if you're losing hair?

Not necessarily.

Hair shedding alone doesn't automatically mean your medication should be discontinued.

The benefits of treatment, the rate of weight loss, nutritional intake, and other medical considerations all matter.

Talk with the clinician managing your weight-loss medication before changing your dose or stopping treatment.

In some cases, addressing inadequate nutrition or adjusting the overall weight-management plan may be more appropriate than discontinuing an otherwise beneficial medication.

For many patients, understanding that telogen effluvium is often temporary can also make the experience less alarming.

Can minoxidil help with GLP-1-related hair loss?

Sometimes, but not everyone experiencing shedding needs medication.

If you have uncomplicated telogen effluvium, hair growth may recover naturally once the underlying trigger has resolved.

Minoxidil may be considered in selected cases, particularly when shedding is prolonged or when there is evidence of underlying androgenetic alopecia, also called pattern hair loss.

The evidence supporting minoxidil specifically for uncomplicated telogen effluvium is limited. Most of its established hair-loss evidence concerns androgenetic alopecia.

Both topical and oral minoxidil are used to treat certain forms of hair loss, although oral minoxidil is prescribed off-label for this purpose.

Neither treatment is guaranteed to help temporary shedding, and oral minoxidil carries potential cardiovascular side effects that require appropriate patient selection.

The first step is determining whether medication is likely to offer a meaningful benefit.

Can weight loss reveal female-pattern or male-pattern hair loss?

Yes. This is an important possibility.

Some people have gradually developing pattern hair loss that isn't particularly noticeable until they experience a period of increased shedding.

After significant weight loss, they may notice a widening part, reduced density at the crown, or thinning around the temples.

In these cases, the temporary shedding may improve while the underlying pattern hair loss persists.

Research on GLP-1 medications and androgenetic alopecia is still evolving. Some observational studies have found associations with increased diagnoses of pattern hair loss, while other reports have suggested that improvements in metabolic health may benefit certain patients.

These findings don't yet establish whether GLP-1 medications directly worsen or improve androgenetic alopecia.

That distinction matters because androgenetic alopecia often benefits from ongoing treatment, while uncomplicated telogen effluvium may resolve without prescription medication.

When should you see a doctor about hair loss after weight loss?

Consider a medical evaluation if:

  • Shedding is persistent, severe, or worsening, particularly if it continues beyond six months.
  • You're noticing a widening part or progressive thinning at the crown or temples.
  • You develop completely bald patches, scalp pain, redness, or significant itching.
  • You have symptoms suggesting a nutritional deficiency, thyroid condition, or another medical problem.
  • Your hair isn't recovering as expected after your weight and nutritional intake have stabilized.

Depending on your history and symptoms, laboratory testing or an in-person scalp examination may be appropriate.

Not all hair loss during GLP-1 treatment needs medication. But not all hair loss during weight loss is temporary, either.

Understanding the cause is the first step toward choosing the right approach.

Hair loss after weight loss isn't always the same problem.

At Verilane Hair, we evaluate your hair loss history, symptoms, medical conditions, and previous treatments to help determine what type of hair loss you may be experiencing.

For some patients, the right approach is addressing potential triggers and allowing time for recovery.

For others, treatment with medications such as minoxidil or other options may be appropriate.

And sometimes, laboratory testing or an in-person dermatology evaluation is the best next step.

Our goal isn't to prescribe medication for every kind of hair loss. It's to recommend the care that makes sense for yours.

Noticing hair loss after weight loss?

Verilane Hair offers individualized online evaluations, with treatment recommendations based on your medical history and symptoms.

Start a Hair Visit — $44

Treatment is subject to physician review and clinical appropriateness. A prescription is not guaranteed. Some types of hair loss require laboratory testing or an in-person examination. Verilane Hair does not prescribe GLP-1 medications.

Medical review: Lindsey McIlvena, MD, MPH

Last reviewed: October 2026

References

  1. Katragadda R, Hayden J, Saltagi AK, et al. Nonscarring Alopecia in Adults Treated With GLP-1s: A Propensity Score Matched TriNetX Cohort Study. The Laryngoscope. 2026.
  2. Leite Júnior AC, Ribeiro Junior HL. GLP-1 Receptor Agonists and Hair Loss: Adverse Effect, Epiphenomenon, or Therapeutic Paradox? Acta Diabetologica. 2026.
  3. Mirmirani P, Fu J. Diagnosis and Treatment of Nonscarring Hair Loss in Primary Care in 2021. JAMA. 2021.
  4. Walter K. Common Causes of Hair Loss. JAMA. 2022.
  5. Seyed Jafari SM, Caro G, Lipner SR, Iorizzo M. The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes? American Journal of Clinical Dermatology. 2026.
  6. Chinisaz F, Maleki T, Najjari K, Miratashi Yazdi SA. Comparative Analysis of Postoperative Hair Loss and Micronutrient Deficiencies After One-Anastomosis Gastric Bypass Versus Sleeve Gastrectomy. Obesity Surgery. 2026.
  7. Lee N, Kim Y. Not All GLP-1 Receptor Agonists Are Alike: Real-World Evidence of Differential Endocrine and Dermatologic Safety. Diabetes/Metabolism Research and Reviews. 2026.
  8. Dakkak M, Forde KM, Lanney H. Hair Loss: Diagnosis and Treatment. American Family Physician. 2024.
  9. Acquired and Inherited Hair Disorders. Rook's Dermatology Handbook. 2023.
  10. Ong MM, Li Y, Lipner SR. Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations. American Journal of Clinical Dermatology. 2026.
  11. Ohyama M, Irisawa R, Uchiyama M, et al. Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open-Label Single-Arm Clinical Trial. The Journal of Dermatology. 2025.
  12. Feaster B, Onamusi T, Cooley JE, McMichael AJ. Oral Minoxidil Use in Androgenetic Alopecia and Telogen Effluvium. Archives of Dermatological Research. 2023.